| CSL Behring AG - Berirab 5 ml, Injektionslösung |
| 00687 | | 02 | | Berirab 5 ml | | Injektionslösung | | J06BB05 | | Tollwut-Immunglobulin | | 05.05.2004 | | |
|
| Composition |
| proteinum humanum 500-850 mg corresp. immunoglobulina min. 95 % corresp. immunoglobulinum humanum anti-rabies min. 750 U.I., immunoglobulinum humanum A max. 15.0 mg, glycinum, natrii chloridum, natrii hydroxidum q.s. ad pH, acidum hydrochloridum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 5 ml, natrium 7.86 mg. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | | Agents auxilliaires | Concentr. |
|---|
| Glycine | | | Immunoglobulinum Humanum A | 15 mg | | Sodium Chlorure | | | Sodium Hydroxide | | | Proteinum Human | 500-850 mg |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 004 | seringue(s) à 5 ml | | | B | | Oui |
|
